Idrees, I., Taqa, G., ALtaaye, S. (2023). Effects of Amitriptyline and Ashwagandha on the Oxidative State and Acetylcholine Esterase Enzyme Activities in Rats. Journal of Applied Veterinary Sciences, 8(2), 104-109. doi: 10.21608/javs.2023.191488.1214
Ismael R. Idrees; Ghada A. A. Taqa; Saba Kh. A. ALtaaye. "Effects of Amitriptyline and Ashwagandha on the Oxidative State and Acetylcholine Esterase Enzyme Activities in Rats". Journal of Applied Veterinary Sciences, 8, 2, 2023, 104-109. doi: 10.21608/javs.2023.191488.1214
Idrees, I., Taqa, G., ALtaaye, S. (2023). 'Effects of Amitriptyline and Ashwagandha on the Oxidative State and Acetylcholine Esterase Enzyme Activities in Rats', Journal of Applied Veterinary Sciences, 8(2), pp. 104-109. doi: 10.21608/javs.2023.191488.1214
Idrees, I., Taqa, G., ALtaaye, S. Effects of Amitriptyline and Ashwagandha on the Oxidative State and Acetylcholine Esterase Enzyme Activities in Rats. Journal of Applied Veterinary Sciences, 2023; 8(2): 104-109. doi: 10.21608/javs.2023.191488.1214
Effects of Amitriptyline and Ashwagandha on the Oxidative State and Acetylcholine Esterase Enzyme Activities in Rats
1Ministry of Health, Nineveh Health Directorate, Mosul, Iraq
2Department of Dental Basic Sciences, College of Dentistry. University of Mosul, Mosul, Iraq
3Dental Basic Sciences Department , College of Dentistry. University of Mosul, Iraq
Receive Date: 02 February 2023,
Revise Date: 25 March 2023,
Accept Date: 28 March 2023
Abstract
Amitriptyline has a long history of effectiveness in treating depression. Due to its side effects, which include oxidative stress and anticholinergic effects, it is used less frequently. Ashwagandha is a substantial herb that has anti-depressant, antioxidant properties. Aim of study: To evaluate the effects of ashwagandha and amitriptyline on the oxidative state of acetylcholine esterase in rat salivary glands. Material and Methods: Four groups of rats were created. Distilled water was given to group I (control), and group II received amitriptyline (10 mg/kg) orally. Ashwagandha root extract (200 mg/kg) was given orally to group III, while similar doses of ashwagandha root extract and amitriptyline were given in combination to group IV. Rats from each group were sacrificed at (7 and 30 days). A blood samples were collected to measure the total antioxidant capacity (TAC). To measuring acetylcholine esterase enzyme, salivary gland tissues were dissected. Results: TAC after 7 days of oral administration showed a non-significant difference between groups while, after 30 days there is a significant decrease in TAC in group II and IV in comparison with that of the control group. Following oral dosing for seven days, acetylcholine esterase measurements revealed an increase in group II and a decrease in group IV as compared to the control group. While after 30 days, all groups' acetylcholine esterase enzyme levels significantly decreased when compared with the control group. It can be Concluded that, Amitriptyline causes oxidative stress and temporarily inhibits acetyl cholinesterase, which results in anticholinergic action. Ashwagandha has acetylcholine esterase inhibitory characteristics and mild salivary gland antioxidant benefits.
ABD AlOBAIDI, I. A., HASSAN, N. A. M., and ALSHAWI l, N. N., 2021. Assessment the oxidative stress potential of fluoxetine and amitriptyline at maximum therapeutic doses for four-week treatment in experimental male rats. Annals of the Romanian Society for Cell Biology, 25(6), 17537-17547. https://annalsofrscb.ro/index.php/journal/article/download/9084/6639
BARUA, N., AZIZ, M. A. I., Tareq, A. M., Sayeed, M. A., Alam, N., ul Alam, N., and Emran, T. B., 2020. In vivo and in vitro evaluation of pharmacological activities of Adenia trilobata (Roxb.). Biochemistry and biophysics reports, 23, 100772. https://doi.org/10.1016/j.bbrep.2020.100772.
BEHL, T., SHARMA, A., SHARMA, L., SEHGAL, A., ZENGIN, G., BRATA, R., and BUNGAU, S., 2020. Exploring the multifaceted therapeutic potential of withaferin A and its derivatives. Biomedicines, 8(12), 571. https://doi.org/10.3390/biomedicines8120571.
BHATTACHARYA, S. K., KUMAR, A., and GHOSAL, S., 1995. Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer's disease and perturbed central cholinergic markers of cognition in rats. Phytotherapy research, 9(2), 110-113.https://doi.org/10.1002/ptr.2650090206.
BIRLA, H., KESWANI, C., RAI, S. N., SINGH, S. S., ZAHRA, W., DILNASHIN, H., and SINGH, S. P., 2019. Neuroprotective effects of Withania somnifera in BPA induced-cognitive dysfunction and oxidative stress in mice. Behavioral and Brain Functions, 15(1), 1-9.https://doi.org/10.1186/s12993-019-0160-4.
COJOCARIU, R. O., BALMUS, I. M., LEFTER, R., HRITCU, L., ABABEI, D. C., CIOBICA, A., and JURCOANE, S., 2020. Camelina sativa methanolic and ethanolic extract potential in alleviating oxidative stress, memory deficits, and affective impairments in stress exposure-based irritable bowel syndrome mouse models. Oxidative Medicine and Cellular Longevity, 23;2020:9510305. https://doi.org/10.1155/2020/9510305.
DAR, N. J., BHAT, J. A., SATTI, N. K., SHARMA, P. R., HAMID, A., and AHMAD, M., 2017. Withanone, an active constituent from Withania somnifera, affords protection against NMDA-induced excitotoxicity in neuron-like cells. Molecular Neurobiology, 54(7), 5061-5073. https://doi.org/10.1007/s12035-016-0044-7.
DURG, S., DHADDE, S. B., VANDAL, R., SHIVAKUMAR, B. S., and CHARAN, C. S., 2015. W ithania somnifera (Ashwagandha) in neurobehavioural disorders induced by brain oxidative stress in rodents: A systematic review and meta-analysis. Journal of Pharmacy and Pharmacology, 67(7), 879-899. https://doi.org/10.1111/jphp.12398.
DUTTA, K., PATEL, P., AND JULIEN, J. P.,2018. Protective effects of Withania somnifera extract in SOD1G93A mouse model of amyotrophic lateral sclerosis. Experimental neurology, 309, 193- 204. https://doi.org/10.1016/j.expneurol.2018.08.008
Dutta, T., Paul, A., Majumder, M., Sultan, R. A., and Emran, T. B., 2020. Pharmacological evidence for the use of Cissus assamica as a medicinal plant in the management of pain and pyrexia. Biochemistry and Biophysics Reports, 21, 100715. https://doi.org/10.1016/j.bbrep.2019.100715.
FAROOQUI, A. A., FAROOQUI, T., MADAN, A., ONG, J. H. J., and ONG, W. Y., 2018. Ayurvedic medicine for the treatment of dementia: mechanistic aspects. Evidence-Based Complementary and Alternative Medicine, Volume 2018, Article ID 2481076, 11 pages https://doi.org/10.1155/2018/2481076.
HAJAM, Y. A., RANI, R., GANIE, S. Y., SHEIKH, T. A., JAVAID, D., QADRI, S. S., and RESHI, M. S., 2022. Oxidative stress in human pathology and aging: molecular mechanisms And perspectives. Cells, 11 (3), 552. https://doi.org/10.3390/cells11030552.
IBRAHEM, R. T. I., MAHMMOD, A. A. M., and TAQA, G. A. T., 2020. The protective and antioxidant effect of catechin and apigenin on some biochemical parameters in blood serum of rats exposed to oxidative stress induced by H2O2. College Of Basic Education Researches. Journal, 16(3), 813-852. http://dx.doi.org/10.33899/berj.2020.166002.
IOVA, A.; MICLE, O.; VICA¸S, L., MICLE, L.,IOVA, S., MURE¸SAN, M., and IONI¸TA, C.A., 2014. Oxidative stress in Alzheimer’s dementia. ˇ Farmacia , 62, 538–546.https://doi.org/10.1016/j.ctim.2019.102294.
KHAN, M. A., SUBRAMANEYAAN M., ARORA, V. K., BANERJEE, B. D., and AHMED, R.S. 2015. Effect of Withania somnifera (Ashwagandha) root extract on amelioration of oxidative stress and autoantibodies production in collagen-induced arthritic rats. Journal of Complementary and Integrative Medicine, 12(2), 117-125 https://doi.org/10.1515/jcim-2014-0075
KUBOYAMA, T., TOHDA, C., and KOMATSU, K., 2005. Neuritic regeneration andsynaptic reconstruction induced by withanolide A. British journal of pharmacology, 144(7), 961-971. https://doi.org/10.1038/sj.bjp.0706122.
KURAPATI, K. R. V., ATLURI, V. S. R., SAMIKKANNU, T., and NAIR, M. P., 2013. Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS One, 8(10), e77624. https://doi.org/10.1371/journal.pone.0077624.
LAFORGIA, M., LAFACE, C., CALABRÒ, C., FERRAIUOLO, S., UNGARO, V., TRICARICO, D., and RANIERI, G., 2021. Peripheral neuropathy under oncologic therapies: a literature review on pathogenetic mechanisms. International Journal of Molecular Sciences, 22(4). https://doi.org/10.3390/ijms22041980.
MANDLIK, D. S., and NAMDEO, A. G., 2021. Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects. Journal of Dietary Supplements, 18 (2), 183-226. https://doi.org/10.1080/19390211.2020.1741484.
MUNIR N, MAHMOOD Z, SHAHID M, ET AL. 2022. Withania somnifera Chemical Constituents’ In Vitro Antioxidant Potential and Their Response on Spermatozoa Parameters. Dose-Response. 20 (1). doi:10.1177/15593258221074936
OMAR, F., TAREQ, A. M., ALQAHTANI, A. M., DHAMA, K., SAYEED, M. A., EMRAN, T. B., and SIMAL-GANDARA, J., 2021. Plant-based indole alkaloids: A comprehensive overview from a pharmacological perspective. Molecules, 26(8), 2297.https://doi.org/10.3390/molecules26082297.
PAL, A., KUMAR, K. H., BHUSHAN, B., and SAHARAN, V., 2017. Ashwagandha root extract inhibits acetylcholine esterase, protein modification and ameliorates H2O2-induced oxidative stress in rat lymphocytes. Pharmacognosy Journal, 9(3). http://dx.doi.org/10.5530/pj.2017.3.52.
PAUL, S., CHAKRABORTY, S., ANAND, U., DEY, S., NANDY, S., GHORAI, M.,. and DEY, A., 2021. Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects. Biomedicine & Pharmacotherapy, 143, 112175. https://doi.org/10.1016/j.biopha.2021.112175.
QIU, S., HE, D., MA, J., LIU, T., and WAITE, T. D., 2015. Kinetic modeling of the electro-Fenton process: quantification of reactive oxygen species generation. Electrochimica Acta, 176, 51-58. https://doi.org/10.1016/j.electacta.2015.06.103.
RODICK, T. C., SEIBELS, D. R., BABU, J. R., HUGGINS, K. W., REN, G., and MATHEWS, S. T., 2018. Potential role of coenzyme Q 10 in health and disease conditions. Nutrition and Dietary Supplements, 10, 1-11. http://dx.doi.org/10.2147/NDS.S112119.
SANKA, N., SANTHIPRIYA, N., and NADENDLA, R. R., 2018. An updated review on Anti- Alzheimer’s herbal drugs. Journal of Drug Delivery and Therapeutics, 8(6), 360-372. http://dx.doi.org/10.22270/jddt.v8i6.2049.
SANTIAGO, L. J., and ABROL, R.,2019. Understanding G Protein selectivity of muscarinic acetylcholine receptors using computational methods. International journal of molecular sciences, 20(21), 5290. https://doi.org/10.3390/ijms20215290.
SINGH, A. K., SINGH, S. K., NANDI, M. K., MISHRA, G., MAURYA, A., RAI, A., and KULKARNI, G. T., 2019. Berberine: a plant-derived alkaloid with therapeutic potential to combat Alzheimer’s disease. Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Central Nervous System Agents), 19(3), 154-170. https://doi.org/10.2174/1871524919666190820160053.
TAQA, G., A AL-SHEIKH, H., and AL-ALLAF, L., 2021. Effects of Melatonin on Behavioural Activities in Acetaminophen-induced Autism in Rat. Journal of Applied Veterinary Sciences, 6(4), 58-66. https://dx.doi.org/10.21608/javs.2021.89536.1098.
THANOON, S., TAQA, G., and ALKATAAN, M., 2022. The Protective Effect of N-acetyl Cysteine on Mitochondrial Copy Number of Salivary Glands after Induction of Oxidative Stress in Albino Rats. Egyptian Journal of Veterinary Sciences, 53(3), 391-402. https://doi.org/10.21608/ejvs.2022.138993.1341.
TIWARI, S., ATLURI, V. S. R., YNDART ARIAS, A., JAYANT, R. D., KAUSHIK, A., GEIGER, J., and NAIR, M. N., 2018. Withaferin a suppresses beta amyloid in APP expressing cells: studies for tat and cocaine associated neurological dysfunctions. Frontiers in aging neuroscience, 10, 291. https://doi.org/10.3389/fnagi.2018.00291.
WHITE, P. T., SUBRAMANIAN, C., MOTIWALA, H. F., and COHEN, M. S., 2016. Natural withanolides in the treatment of chronic diseases. Anti-inflammatory nutraceuticals and chronic diseases, 329-373. https://doi.org/10.1007/978-3-319-41334-1_14.
YOUSIF, S., TAQA, G., and TAHA, A., 2022. The Effects of Melatonin on Caspase-3 and Antioxidant Enzymes Activity in Rats Exposed to Anticancer Drug. Egyptian Journal of Chemistry. Articles in Press, Accepted Manuscript, Available Online from 17 May 2022 https://doi.org/10.21608/ejchem.2022.132312.5840.
ZAHIRUDDIN, S., BASIST, P., PARVEEN, A., PARVEEN, R., KHAN, W., and AHMAD, S., 2020. Ashwagandha in brain disorders: A review of recent developments. Journal of Ethno-pharmacology , 257, 112876. https://doi.org/10.1016/j.jep.2020.112876.
View on SCiNiTO
Top